By Kat Black | June 11, 2024
A $700 million settlement reached by Johnson & Johnson with attorneys general from 43 states prohibits the pharmaceutical company from manufacturing, selling or distributing its talcum-based body powder products, which are known to increase the risk for cancer, in the United States.
By Marianna Wharry | June 4, 2024
"We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded 'semaglutide' products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines," said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.
By Ross Todd | June 3, 2024
The work that Wallach and his wife Sandra Abrevaya have done establishing the I AM ALS foundation since his 2017 diagnosis is featured in a new documentary recently released on Amazon Prime.
By Ross Todd | May 31, 2024
Defense lawyers for GSK, led by Tarek Ismail of Goldman Ismail, and Boehringer Ingelheim, led by Andrew Bayman of King & Spalding, won a defense verdict from state court jurors who rejected a claim that the discontinued heartburn drug Zantac caused an Illinois woman's colon cancer.
By Brenda Sapino Jeffreys | May 23, 2024
CEO Noah Heller said revenue growth also resulted from strong demand in practices including insolvency and restructuring, private wealth, structured finance, and private credit, and, in the second half of the year, litigation.
By Marianna Wharry | May 22, 2024
"We are very pleased the court granted class certification to more than 1,700 CITGO employees and pensioners in this important ERISA case," one of the plaintiffs' counsel, Michelle C. Yau, chair of Cohen Milstein's ERISA practice, said in a statement. "This ruling and the court's recent order denying summary judgment pave the way for the class claims to move forward to trial and affirm our confidence that our clients will prevail."
By Brenda Sapino Jeffreys | May 22, 2024
A startup and its two founders sued Michael Best & Friedrich and two lawyers in Chicago, alleging they mishandled a business reorganization.
By Brenda Sapino Jeffreys | May 21, 2024
Mayer Brown partner Tom Panoff, who does commercial and antitrust litigation, said the move to Sheppard Mullin is good for his practice and clients.
By Marianna Wharry | May 21, 2024
"Whether MOC is a sound policy of accrediting physicians is a separate question from whether it restricts competition in the CME product market. Since the second amended complaint does not plausibly allege the latter, the plaintiffs' tying claims fail," U.S. District Judge Jeremy C. Daniel wrote.
By Marianna Wharry | May 15, 2024
"The jury's verdict is bittersweet for this wonderful family, which has been devastated by Craig Pierce's injury and the loss of his ability to function independently and practice law," Christopher Hurley, a founding partner at Hurley McKenna & Mertz, said in a statement.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
GlobeSt. Women of Influence Conference celebrates the women who drive the commercial real estate industry forward.
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Cullen and Dykman is seeking an associate attorney with a minimum of 5+ years in insurance coverage experience as well as risk transfer and ...
McCarter & English, LLP is actively seeking a midlevel insurance coverage associate for its Newark, NJ and/or Philadelphia, PA offices. ...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...